Synthetic attenuated virus engineering (SAVE) is an emerging technology that enables rapid attenuation of viruses. In this study, by using SAVE we demonstrated rapid attenuation of an arterivirus, porcine reproductive and respiratory syndrome virus (PRRSV). The major envelope GP5 gene of PRRSV was codon-pair deoptimized aided by a computer algorithm. The codon-pair deoptimized virus, designated as SAVE5 with a deoptimized GP5 gene, was successfully rescued in vitro. The SAVE5 virus replicated at a lower level in vitro with a significant decrease of GP5 protein expression compared to the wild-type PRRSV VR2385 virus. Pigs experimentally infected with the SAVE5 virus had significantly lower viremia level up to 14 days post-infection as well as significantly reduced gross and histological lung lesions when compared to wild-type PRRSV VR2385 virus-infected pigs, indicating the attenuation of the SAVE5 virus. This study proved the feasibility of rapidly attenuating PRRSV by SAVE.
Introduction
Porcine reproductive and respiratory syndrome (PRRS) is arguably the most economically-important swine disease facing the global swine industry today causing devastating economic losses of approximately $664 million per year in the United States alone (Lunney et al., 2010; Neumann et al., 2005; Nieuwenhuis et al., 2012) . PRRS is caused by an enveloped, single-stranded, positive-sense RNA virus, PRRS virus (PRRSV) (Benfield et al., 1992; Cavanagh, 1997; de Groot et al., 2012) . The genome of PRRSV is approximately 15 kb in size and consists of structural genes (ORF2-ORF7) and non-structural genes (ORF1a and ORF1b) (Allende et al., 1999; Meulenberg et al., 1993; Nelsen et al., 1999) . PRRSV is extremely heterogenic with at least 9 distinct subtypes among the type 2 PRRSV and at least 4 distinct subtypes of type 1 PRRSV (Shi et al., 2010; Stadejek et al., 2013) . The current available vaccines, although effective against homologous or closely-related PRRSV strains, are not very effective against heterologous PRRSV strains circulating in the swine population.
Extensive genetic variation and recombination led to frequent emergence of new and more virulent strains of PRRSV worldwide Shi et al., 2010; Tian et al., 2007) . Therefore, rapid attenuation of emerging variant field strains of PRRSV for further development of effective vaccines is urgently needed. Traditional methods for attenuating PRRSV and other viruses are usually time-consuming, and have the additional disadvantage that the traditionally attenuated PRRSVs have an inherent risk of reversion to a pathogenic phenotype (Meng, 2000) . To overcome these problems associated with traditional virus attenuation, in this study we utilized a computer-based codon-pairs deoptimization technology, synthetic attenuated virus engineering (SAVE), for rapid attenuation of PRRSV.
It is known that, among the synonymous codon pairs encoding the same amino acid residues, some codon pairs occur more frequently than others in certain species (Fedorov et al., 2002; Gutman and Hatfield, 1989; Moura et al., 2007) , which is known as codon-pair bias. Different species have different codon-pair biases, and it has been demonstrated that the codon-pair bias is related to the efficiency of the protein synthesis thereby affecting the accumulation of synthesized proteins inside cell (Coleman et al., 2008; Mueller et al., 2010) . Therefore, the principle of the SAVE technology is that codon-pair deoptimization of a key viral gene decreases the protein expression levels of the corresponding gene that are related to viral virulence. The codon-pair deoptimization is based on computer-aided modification of the naturally optimized pairs of codons in a viral gene sequence without altering the codon bias and the amino acid sequence (Mueller et al., 2010) . The SAVE technology was first applied to attenuate poliovirus (Coleman et al., 2008) by using a computer algorithm to rearrange codons existing in a poliovirus gene fragment to change the pattern of codon pairs but preserve codon bias or amino acids. It was shown that the efficiency of polio viral protein translation was decreased by codon-pair deoptimization, which led to poliovirus attenuation. The SAVE approach was also applied to successfully attenuate influenza virus (Mueller et al., 2010) . Unfortunately, the promising potential of this novel approach to rapidly attenuate other important viruses especially veterinary viruses has not been explored further.
The ORF5 gene of PRRSV encodes the major envelope glycoprotein GP5, which is critical to form viral particles with the M protein, encoded by the ORF6 (Wissink et al., 2005) . The GP5 protein forms a heterodimer with the M protein which is important for viral assembly (Van Breedam et al., 2010) . This GP5-M dimer is involved in virus entry particularly in the alveolar macrophages, the host cells in pigs (Delputte et al., 2007) . In addition, the GP5 is associated with apoptosis induced by PRRSV in MARC-145 cells (Gagnon et al., 2003; Miller and Fox, 2004) . It has also been demonstrated that the GP5 contains the major virulence determinants of PRRSV (Kwon et al., 2008) . The GP5 contains a N-terminal signal peptide which overlaps with a small structural protein encoded by ORF5a and may play a role in viral replication (Johnson et al., 2011) .
In this study, we utilized the computer-aided codon-pair deoptimization approach to successfully attenuate PRRSV. We demonstrated that, by deoptimization of the codon-pairs of the major envelope GP5 gene, the modified PRRSV with a codon-pair deoptimized GP5 gene was successfully rescued. The growth capacity and virulence of the modified virus was compared with the wt PRRSV both in vitro and in vivo.
Results

Characteristics of codon-pair deoptimized PRRSV GP5 gene
The distribution of the CPB score calculated from the available swine genes (ftp://ftp.ensembl.org/pub/release-66/fasta/sus_scrofa/ cdna/) is similar to that of human genes, which is in the range of 0-0.1 (data not shown). The CPB scores of PRRSV GP5 gene was calculated and the original CPB score for the gene was in the range from À 0.1 to 0.1. A computer algorithm was used to switch the existing codons in the GP5 gene to more underrepresented codonpairs in order to decrease the CPB score of the GP5 gene to approximate À 0.3. The characteristic of the codon-pair deoptimized GP5 gene segment is shown in Table 2 . The alignment of the GP5 gene sequences between the wt VR2385 virus and the codon-pair deoptimized SAVE5 virus is shown in Fig. 1 .
Codon-pair deoptimized virus SAVE5 was successfully rescued from recombinant infectious clone in vitro:
The recombinant DNA-launched PRRSV infectious clone with codon-pair deoptimized GP5 gene was designated as pIR-VR2385-SAVE5. The SAVE5 virus with codon-pair deoptimized GP5 gene was successfully rescued from the infectious clone pIR-VR2385-SAVE5. The infectivity of the recused SAVE5 virus was confirmed by IFA with an anti-PRRSV N monoclonal antibody in the infected MARC-145 cells (Fig. 2) .
Codon-pair deoptimization of GP5 gene reduces the corresponding viral protein synthesis in the rescued viruses
To investigate if the codon-pair deoptimization of the GP5 affected the translation of the corresponding gene, western blot analyses were performed to assess the viral protein expression levels in vitro. The results showed that, at 24 hpi, the expression levels of codon-pair deoptimized GP5 from SAVE5 virus-infected cells were significantly reduced when compared to wt VR2385 virus-infected cells. However, the expression levels of the viral nucleocapsid protein N or internal control GAPDH in cells infected with the codon-pair deoptimized SAVE5 virus was not significantly different from that of wt virus-infected cells (data not shown).
Codon-pair deoptimization of GP5 gene decreased the growth kinetics of PRRSV in vitro
To compare the growth characteristics between the codon-pair deoptimized virus (SAVE5) and the wt VR2385 virus, the growth kinetics of the two viruses were analyzed by infecting PK15-CD163 cells as well as PAM cells with each virus at the same m.o.i. of 0.1. The results showed that, in PK15-CD163 cells, the SAVE5 virus had lower infectious titers and reduced levels of replication at all time points with statistically significant differences observed after 36 hpi (Fig. 3A) . Similarly, in PAM cells, the codon-pair deoptimized SAVE5 virus showed significantly lower infectious titers at all time points when compared with the wt VR2385 virus (Fig. 3B) . Experimental infection of pigs with the codon-pair deoptimized SAVE5 virus resulted in significantly lower viral RNA loads and lower infectious titers in sera and lung tissues compared to wt virusinfection
The viral RNA loads in pig sera were quantified by qPCR. The group of pigs infected with the codon-pair deoptimized SAVE5 virus had significantly decreased viral RNA loads in sera at 7 dpi and 14 dpi when compared to the group of pigs infected with wt VR2385 (p ¼0.032, p ¼0.036) (Figs. 4A and B) . The viral infectious titers in sera were also measured and, similar to viral RNA loads, there was also a significantly lower infectious virus titer in the SAVE5 virus-infected pigs compared to wt VR2385 virus-infected pigs at both time points (p ¼0.0097, p ¼0.048) (Figs. 5A and B). . PRRSV RNA loads in serum samples and lung tissues from pigs experimentally infected with codon-pair deoptimized SAVE5 virus or with wt VR2385 virus. (A) PRRSV RNA loads in serum samples at 7 dpi from the pigs (n¼ 8) inoculated with SAVE5, VR2385 or media ("NEG"), respectively. There was a significant difference (indicated with n) in serum viral RNA loads between the GP5 codon-pair deoptimized SAVE5 virus-infected group and wt VR2385 virus-infected group. (B) PRRSV RNA loads in serum samples at 14 dpi. There was a significant difference (indicated with n) in serum viral RNA loads between the SAVE5 virus-infected group and wt VR2385 virus-infected group. (C) Viral RNA loads in the lung tissues collected during necropsy at 14 dpi. A significant difference (indicated with n) between the SAVE5 virus-infected group and the wt VR2385 virus-infected group are observed. The standard error bars are indicated. The detection limit of the experiment is 100 viral RNA copy numbers/ml. The numbers with circles along the x axis indicate the numbers of animals in each group that tested negative for viral RNA. . Viral infectious titers in serum samples of pigs experimentally infected with the GP5 codon-pair deoptimized SAVE5 virus or wt VR2385 virus. Viral infectious titers in serum samples of pigs were quantified as TCID 50 /ml. There are significant differences at both 7 dpi and 14 dpi between the SAVE5 virus-infected group and wt VR2385 virusinfected group (indicated with n). The standard error bars are indicated. The detection limit of the experiment is 10 TCID 50 /ml. The numbers with circles along the x axis indicate the numbers of animals in each group that tested negative for viral infectious titer.
Likewise, there were also significantly lower viral RNA loads in the lung tissues from the SAVE5-infected pigs compared to wt VR2385 virus-infected pigs (p ¼0.047) (Fig. 4C ).
Pigs infected with the codon-pair deoptimized SAVE5 virus had significantly reduced macroscopic and microscopic lung lesions compared to the pigs infected with the wt VR2385 virus Pigs inoculated with the GP5 gene deoptimized virus SAVE5 or DMEM showed absent or only very mild macroscopic lung lesions, whereas pigs inoculated with the wt VR2385 virus developed pronounced macroscopic lung lesions. The control pigs inoculated with DMEM showed no lesions. The difference of the macroscopic lung lesions between the codon-pair deoptimized SAVE5 virus group and wt VR2385 virus group was significant (p¼ 0.0057) (Fig. 6A) . The mean scores of the microscopic lung lesions were 1.38 70.42 for the SAVE5 virus-infected pigs, and 3.88 70.30 for the wt VR2385 virus-infected pigs, and 0.87 70.23 for the negative control pigs. Similar to the gross lung lesions, the codon-pair deoptimized SAVE5 virus-infected group had also a significantly reduced mean interstitial pneumonia score compared to the wt VR2385 virus-infected group (p¼ 0.0001) (Fig. 6B) .
The codon-pair deoptimized GP5 gene in the SAVE5 virus is genetically stable in vitro and in vivo
To determine if the codon-pair deoptimized GP5 gene is stable in vitro, the SAVE5 virus were serially passaged in PAM cells for 10 passages, and the codon-pair deoptimized GP5 gene of the SAVE5 virus harvested from each passage at 24 h post-infection was amplified by RT-PCR and sequenced. Sequence analysis revealed that there was no change in the sequence of the GP5 gene of SAVE5 virus after 10 serial passages, indicating that the codon-pair deoptimized GP5 gene was genetically stable during infection of PAMs in vitro. To determine if the codon-pair deoptimized GP5 gene is stable in vivo during SAVE5 virus replication in pigs, we amplified and sequenced the GP5 gene region of the SAVE5 virus recovered from the infected pigs at 14 dpi. Sequence analysis revealed that the GP5 gene sequences of the SAVE5 virus recovered from the infected pigs at 14 dpi were identical to that of the original SAVE5 virus inocula, indicating that the codon-pair deoptimized GP5 gene was genetically stable in pigs during in vivo virus replication.
Discussion
The frequent emergences of novel and more virulent strains of PRRSV worldwide necessitate the need for rapid development of vaccines to combat against these emerging variant strains of PRRSV. The SAVE approach based on codon-pair deoptimization is an emerging new technology that can rapidly attenuate viruses for further development of potential candidate vaccines. Unfortunately this promising technology has only been used for poliovirus and influenza virus attenuation and has not been broadly explored for rapid attenuation of other important viruses, especially important veterinary viruses (Coleman et al., 2008; Mueller et al., 2010) . In this study, we successfully attenuated PRRSV, an important veterinary pathogen, by using the SAVE approach. PRRSV major envelope gene GP5 was selected in this study for codon-pair deoptimization because of its critical roles in viral assembly and virulence. After codon-pair deoptimization of the PRRSV GP5 gene with a computer-aided algorithm, we successfully rescued a virus, SAVE5, with codon-pair deoptimized GP5 gene. The codon-pair deoptimized virus SAVE5 was shown to be viable in vitro.
In vitro characterization of the SAVE5 virus revealed that, as expected, codon-pair deoptimization led to a reduced translation of the GP5 gene in the SAVE5 virus while the production of PRRSV N protein in the codon-pair deoptimized virus as well as the internal control GAPDH levels in the same cells were not affected (data not shown), indicating the specificity of the impact of codonpair deoptimization on viral protein translation by SAVE. In the porcine kidney cell line PK15 expressing the PRRSV receptor CD163, the codon-pair deoptimized SAVE5 virus replicated to significantly lower titers after 36 h post-infection when compared to that of the wt VR2385 virus. Similarly, in its in vivo natural target cells PAM, the codon-pair deoptimized SAVE5 virus showed significantly lower titers at all time points when compared to that of the wt VR2385 virus, an indication of attenuation phenotype in vitro.
To determine if the codon-pair deoptimized virus was attenuated in vivo, we conducted a comparative pathogenicity study in SPF pigs. The results demonstrated that infection of pigs with the codon-pair deoptimized SAVE5 virus resulted in significantly lower viral RNA loads in sera and lung tissues when compared to the wt VR2385 virus-infected pigs. Similarly, the codon-pair deoptimized SAVE5 virus also produced significantly lower infectious virus titers in sera of infected pigs. Importantly, both the macroscopic and microscopic lung lesion scores were significantly reduced in SAVE5 virus-infected pigs compared to those in wt VR2385 virus-infected pigs, indicating that the SAVE5 virus is attenuated in vivo. The mechanism of attenuation of SAVE5 virus seems to be due to the impact of SAVE approach on the GP5 protein expression level, which correlated to the apoptosis of infected cells thus affecting the virus pathogenicity in vivo. In addition, the GP5 involves in the assembly of PRRSV particles, therefore less expression of the GP5 proteins may decrease the yield of complete assembled viral particles, which can affect the generation of infectious viral titer thus leading to the attenuation of the SAVE5 virus. The codon-pair deoptimized GP5 sequence in the SAVE5 virus was genetically stable up to 10 serial passages in PAM cells in vitro and up to 14 dpi in vivo. The large numbers of nucleotide changes in the deoptimized GP5 gene sequence (Fig. 1 ) not only significantly decrease the chance of reversion to virulence phenotype of the attenuated SAVE5 virus also but reduce the chance of homologous recombination with other field strains of PRRSV as well. However, it is possible that mutations may still occur in other parts of the virus genome since we did not sequence the entire genome of the SAVE5. Compared to the traditional virus attenuation approach which typically requires serial passages of a pathogenic virus in cell cultures, the SAVE technology is much more rapid for virus attenuation based on direct synthesis of codon-pair deoptimized viral gene sequence.
In summary, we successfully used SAVE to rapidly attenuate PRRSV. The SAVE5 virus with a codon-pair deoptimized GP5 gene was successfully rescued and displayed an attenuation phenotype both in vitro and in vivo. A unique advantage of the SAVE approach is that it effectively attenuates PRRSV without altering the antigenicity of the viral protein on the virion. Therefore, the attenuated SAVE5 virus should retain the same antigenicity as the wildtype virus. The results from this study demonstrated the feasibility of rapid attenuation of PRRSV by the SAVE approach. Whether or not the attenuated SAVE5 could be useful for further development into a potential candidate MLV against PRRSV requires future indepth immunogenicity and challenge studies, which is not the scope of the present study aiming to assess the PRRSV attenuation feasibility by SAVE. Nevertheless, the SAVE approach appears to have a broad application in rapidly attenuating important viruses.
Materials and methods
Application of computer-based algorithm to deoptimize codon pairs of PRRSV GP5
We utilized the SAVE approach (Coleman et al., 2008) to deoptimize the PRRSV GP5 gene by minimizing their codon pair bias. The major envelope GP5 gene was chosen because it is one of the major virulence determinants of PRRSV. In the GP5 gene, a region of 146 nucleotides (nt) overlapping with ORF5a and a 16-nt region overlapping with ORF6 were excluded for codon-pair deoptimization to avoid the alteration of unrelated proteins.
The representation of all amino acids (excluding stop codon) in terms of nucleotide triplets is 61, which produces the numbers of possible codon pairs as 61 2 ¼3721. The Codon Pair Score (CPS) is defined as the natural log of the ratio of the observed over the expected number of occurrences of each codon pair over all coding regions. Given two codons A and B, and the corresponding amino acid X and Y, respectively, the CPS is calculated with the equation below: 
This denotes the average CPS over an entire gene. For a given gene, and two amino acid pairs within which, if they are the same in terms of amino acids, but utilize different codons, we can exchange the codon within one amino acid pair with the other, to manipulate the CPB. We used an approximation algorithm -simulated annealing -to minimize the CPB.
To preserve the functionality of the attenuated GP5 gene, we maintained the secondary structure of the gene while attempting the attenuation, and this was accomplished by restricting the difference of the free energy of the folding of the newly generated gene sequence with the original one. We used the RNAfold software in the Vienna RNA package (Schuster et al., 1994) to compute the minimum free energy (MFE).
DNA synthesis and cloning
The codon-pair deoptimized GP5 gene sequence was commercially synthesized de novo (Genscript). The codon-pair deoptimized GP5 gene fragment was amplified with a pair of primers CpD5F/CpD5R (Table 1) . For cloning purposes, the flanking fragments derived from the wt viral sequence containing naturallyoccurring unique restriction sites were fused to the corresponding codon-pair deoptimized GP5 gene fragment (Table 1 ) and the fusion gene fragment was subsequently cloned into the backbone of a DNA-launched infectious clone of PRRSV, pIR-VR2385-CA, to replace the original GP5 gene sequence. This recombinant clone was designated as pIR-VR2385-SAVE5.
Cells and viruses
The only susceptible cell line that is readily available to propagate PRRSV is the monkey kidney cell line MARC-145. However, in order to accurately assess the translation efficiency and replication of the codon-pair deoptimized viruses, a cell line of porcine origin that possesses the same translation system as the natural host animal of PRRSV is needed. Therefore, in this study, we utilized a susceptible porcine kidney PK15 cell line stably expressing PRRSV receptor molecule CD163, PK15-CD163, which was recently established in our lab for PRRSV infection following a similar protocol described previously (Calvert et al., 2007) . Cells were maintained in modified Eagle medium (MEM) (Invitrogen) supplemented with 2-10% fetal bovine serum (FBS) (Invitrogen), 1% antibiotic/antimycotic (Fisher), 1% sodium pyruvate (Invitrogen), and 1X MEM non-essential amino acids solution (Invitrogen).
Hygromycin at 100 μg/ml was added to growth medium for selection and maintenance of the PK15-CD163 cells.
Additionally, the in vivo target cells of PRRSV, porcine alveolar macrophages (PAMs), were also used to analyze the growth capacity of the codon-deoptimized virus in vitro. The PAMs were obtained by a lung lavage of a piglet from a PRRSV-free university research herd and maintained in RPMI 1640 media (Invitrogen) supplemented with 10% FBS (Invitrogen), 1% antibiotic/antimycotic (Fisher). BHK-21 cells and MARC-145 cells were used for PRRSV rescue and propagation. Both cells were cultured in Dulbecco's modified Eagle medium (DMEM) (ATCC) supplemented with 2-10% FBS and 1% penicillin/streptomycin (Fisher).
Rescue of codon-pair deoptimized PRRSV
To rescue the codon-pair deoptimized virus, recombinant clone pIR-VR2385-SAVE5 was transfected into BHK-21 cells as described previously (Ni et al., 2011) . The transfected cells were harvested at 24 h post-transfection by freeze-thaw 3 times, and the cell lysates were passaged onto MARC-145 cells. To confirm the rescue of the codon-pair deoptimized virus, an immunofluorescence assay (IFA) with an anti-PRRSV N antibody was performed at 48 h postinfection (hpi) as previously described (Ni et al., 2011) . After three passages of the virus on MARC-145 cells, the genomic region spanning the codon-pair deoptimized GP5 gene from the rescued virus was amplified and sequenced to confirm the successful rescue of the virus and the genetic stability of the codon-pair deoptimized GP5 gene in vitro. The virus rescued from pIR-VR2385-SAVE5 was designated as SAVE5.
Growth characterization of codon pair deoptimized SAVE5 virus in vitro
To analyze the impact of codon-pair deoptimization of GP5 gene on the growth capacity of the rescued virus in vitro, a PRRSVsusceptible porcine kidney cell line PK15-CD163 and the in vivo natural target cells of PRRSV, PAM, were used for viral infection and growth characterization. For PK15-CD163 cells, confluent monolayers of PK15-CD163 cells seeded in 96-well plates were infected with the wt PRRSV VR2385 as well as with the codon-pair deoptimized SAVE5 virus at multiplicity of infection (m.o.i.) of 0.1, respectively. The infected cells were harvested at 6, 12, 24, 36, 48, 60 and 72 hpi, and the infectious titers of the viruses were determined as described previously (Ni et al., 2013) . Triplicate experiments were performed in this study. Similarly, the growth capacity of the SAVE5 was also characterized in PAM cells essentially as described for the PK15-CD163 cells.
Western blotting analysis
To analyze the effect of codon-pair deoptimization of GP5 gene on viral protein translation, we performed western blot analyses. Briefly, at 24 hpi, the infected PK15-CD163 cells were rinsed twice with 4 1C phosphate-buffered saline (PBS) and lysed with RIPA buffer. The BCA Protein Assay Kit (Pierce) was used, according to the manufacturer's instruction, to quantify the total protein concentration of the lysed samples. The same amount of the total proteins (50 μg) from each sample was loaded and separated by SDS-polyacrylamide gel electrophoresis (PAGE) and subsequently transferred to a nitrocellulose membrane. For Western blotting analysis, the membrane was first blocked with Odyssey blocking buffer (Licor Biosciences) for 1 h, and then incubated with polyclonal antibody specific to GP5 (Biomatik), N protein (SR30 from Rural Technologies, Inc.) or GAPDH (Thermo Scientific) diluted in PBS with 0.05% Tween 20 (PBST) and 10% blocking buffer at 4 1C overnight. After three washes of 10 min each with PBST, the membrane was incubated again with either IRDye 680RD Goat anti-Mouse IgG or IRDye 800CW Goat anti-Rabbit IgG according to the respective primary antibody (Licor Biosciences) diluted in 0.05% PBST with 10% blocking buffer for 1 h at room temperature. After three washes of 10 min each with PBST, the proteins were visualized via the Licor Odyssey imaging device (Licor Biosciences).
Pathogenicity study of the codon-pair deoptimized SAVE5 virus in specific-pathogen-free (SPF) pigs
To determine the virulence of the codon-pair deoptimized SAVE5 virus, a comparative pathogenicity study was conducted in SPF pigs. The animal study was approved by the Institutional Animal Care and Use (IACUC) Committees from Virginia Tech and Iowa State University. A group of 8 pigs were each intramuscularly inoculated with 2 ml of SAVE5 virus (2 Â 10 5 TCID 50 /pig), respectively. Another group of 8 pigs were each mock-infected with 2 ml of the cell culture media as negative controls, and a third group of 8 pigs were each intramuscularly inoculated with 2 ml of the wt VR2385 virus (2 Â 10 5 TCID 50 /pig) as positive controls. Serum samples from each pig were collected prior to inoculation and weekly thereafter and tested for viral loads by quantitative RT-PCR and for infectious virus titers by a TCID50 infectivity assay in MARC-145 cells. All pigs were euthanized at 14 dpi, and the gross lung lesions were evaluated and scored at the time of necropsy according to a published method (Halbur et al., 1995) . Lung tissues from each pig were also collected and fixed in 10% neutral buffered formalin and processed for histological examination of microscopic lung lesions (Halbur et al., 1995) .
Quantitation of viral RNA loads using SYBR-green based qRT-PCR
To quantify the viral RNA loads in serum and lung tissues from each pig after infection with virus or DMEM, a SYBR-Green based quantitative RT-PCR was used. Total RNAs were extracted from serum or lung tissue samples using TRI Reagent (MRC) and reverse transcribed to cDNA using the Superscript II kit (Invitrogen) with primer RTspR51 (Table 1 ). The subsequent qPCR assay was conducted in a CFX96 real-time PCR system (Bio-Rad). A pair of primers located in the conserved regions of PRRSV N gene (realtime2F and realtime2R, Table 1 ) was designed by utilizing the Beacon software and used in the PCR reactions as described (Ni et al., 2013) . A dissociation curve analysis was performed using the instrument's default setting immediately after each PCR run to confirm the specificity of PCR product. Reaction was performed in triplicates.
Quantification of infectious virus titers in serum samples of infected pigs by an infectivity assay
To determine the infectious virus titers in serum samples, a TCID 50 assay were performed as described previously (Ni et al., 2013) . Briefly, 10-fold serially diluted serum samples (10 ) collected at different dpi's from pigs were used to infect MARC-145 cells seeded in 96-well plates. After 1 h incubation at 37 1C, the inocula were removed and the cells were washed twice with PBS. The cells were maintained in fresh DMEM media supplemented with 2% fetal bovine serum for 48 h at 37 1C before being fixed with 80% acetone (Sigma). The infectious titer of each serum sample was subsequently quantified using an immunofluorescence-based assay (Ni et al., 2013) . Titration was performed in triplicates in this study.
Evaluation of gross and histological lesions in the lungs of infected pigs
The gross and histological lung lesions were evaluated by a veterinary pathologist who was blind to the treatment groups of the pigs. The scoring system for estimating the macroscopic lung lesions was based on the approximate volume that each lung lobe contributes to the entire lung as described previously (Halbur et al., 1995; Ni et al., 2013) . Histological lung sections representative of all lobes from each pig were scored for the presence and severity of interstitial pneumonia ranging from 0 (normal) to 6 (severe diffuse interstitial pneumonia) as previously described (Halbur et al., 1995; Ni et al., 2013) .
